135 related articles for article (PubMed ID: 16020947)
1. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
Assié MB; Consul-Denjean N; Koek W; Newman-Tancredi A
Pharmacology; 2005 Oct; 75(2):63-8. PubMed ID: 16020947
[TBL] [Abstract][Full Text] [Related]
2. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
4. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
[TBL] [Abstract][Full Text] [Related]
6. Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
Assié MB; Sleight AJ; Koek W
Eur J Pharmacol; 1993 Jun; 237(2-3):183-9. PubMed ID: 7689973
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
[TBL] [Abstract][Full Text] [Related]
9. Multiple [3H]-nemonapride binding sites in calf brain.
Helmeste DM; Tang SW; Li M; Fang H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):17-21. PubMed ID: 9228185
[TBL] [Abstract][Full Text] [Related]
10. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
12. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
Dean B; Hussain T; Scarr E; Pavey G; Copolov DL
Life Sci; 2001 Aug; 69(11):1257-68. PubMed ID: 11521750
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
14. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
Lidow MS; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
Kapur S; Seeman P
J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
[TBL] [Abstract][Full Text] [Related]
17. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Malmberg A; Jerning E; Mohell N
Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
[TBL] [Abstract][Full Text] [Related]
18. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
Tang SW; Helmeste DM; Fang H; Li M; Vu R; Bunney W; Potkin S; Jones EG
Brain Res; 1997 Aug; 765(1):7-12. PubMed ID: 9310388
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
[TBL] [Abstract][Full Text] [Related]
20. Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
Oka T; Hamamura T; Lee Y; Miyata S; Habara T; Endo S; Taoka H; Kuroda S
Life Sci; 2004 Nov; 76(2):225-37. PubMed ID: 15519367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]